Antibodies to functional glutamate receptor subunits were utilized as
probes to characterize glutamatergic receptors in human postmortem bra
in tissue. Crude membranes from rat, monkey, and various dissected hum
an postmortem brain regions were fractionated by SDS-PAGE and electrot
ransferred to nitrocellulose. Using antisera raised against rat antige
ns for AMPA/kainate (GluR1-3) and kainate (GluR5) glutamate receptor s
ubunits, we have been able to detect specific bands on Western blots i
n rat, monkey, and human postmortem brain tissue. These antisera recog
nized bands at approx 105 kDa for the GluR1-3 and 115 kDa for GluR5 in
humans, monkeys, and rats. All of these glutamate receptor subtypes a
ppear to be glycosylated. We observed varying levels of expression in
the human brain areas examined, with the highest degree of expression
in the hippocampus and temporal cortex for AMPA/kainate receptor subun
its, and in the cortex and cerebellum for the kainate receptor subunit
s. In addition, considerable heterogeneity in expression was observed
between patient samples with these antisera, as well as with antisera
to the structural protein, NCAM. Our studies indicate that glutamaterg
ic receptor protein changes related to various human disease states ma
y be examined in human postmortem tissue by Western blotting technique
s utilizing these antibodies raised to the rat protein.